Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder
Charbone Hydrogene Annonce un Financement de Reglements de Dettes par Emission d'Unites pour un Montant Total de 1,3M$
Cartier Signs Agreement with Exploits Discovery To Option 100% of the Benoist, Fenton and Wilson Properties Â
